The relative safety of e-cigarettes over tobacco cigarettes is their primary selling point.

1. The financial conflicts of interest involved in these commentaries were not with tobacco companies, but with pharmaceutical companies. Every instance where "tobacco company" appears should be replaced with "pharmaceutical company," and "Big Tobacco" should be replaced with "Big Pharma." The article errantly refers to R.J. Reynolds, Lorillard, Brown & Williamson, Star Scientific, U.S. Tobacco, Liggett, and Santa Fe Natural Tobacco Company. These companies should have been listed as Elan Pharmaceutical, SmithKline Beecham, Glaxo Wellcome, GlaxoSmithKline, Nabi Biopharmaceuticals, Pfizer, Sanofi-Synthelabo, sanofi-aventis, Lederle, Ciba-Geigy, McNeil Consumer Products, and Pharmacia. We apologize for any inconvenience these errors may have caused.

If any of my readers can find out, please let me know because it is baffling to understand why a long-time anti-smoking advocate like Stan would want to protect cigarettes from the most serious competition they have ever faced. If this flavoring ban is enacted, Stan will have the rare role of being not only the hero of the tobacco control movement but the hero of the cigarette promotion movement as well.

Today, I express my opinion that the use of these studies to draw conclusions about the efficacy of e-cigarettes for smoking cessation is not just unscientific, but dishonest as well.

I will address each of these two provisions of the deeming regulations, showing why they represent a devastating blow to the public's health and a huge gift for combustible cigarettes and in turn, for cigarette-related disease and death.

LAST：New technology! Promotion gift for globe, magic revolving globe |NEXT：2014 DNA 35 Chip Box Mod Clone DNA 35 Chip